Sarena Francis Willard
SEC-identified person · CIK 1423786 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| 89bio, Inc. ETNB | Chief Operating Officer | filed 2024 - 2025 |
| Brookline Capital Acquisition Corp. BCACU | President and COO | filed 2022 - 2023 |
| Five Prime Therapeutics, INC. FPRX | SVP, Gen Counsel & Secretary | filed 2013 - 2021 |
| Facet Biotech Corp FACT | VP, Gen Counsel & Secy | filed 2008 - 2010 |
| Protein Design Labs INC/DE pdli | VP/Gen Counsel/Secy | filed 2008 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.